Skip to main content
OpenTrials
Completed

NCT Number: NCT02346331

Epidemiology, Acute Management, and Outcomes of Patients With Sepsis Presenting to a Referral Hospital in Western Kenya

Sepsis is a clinical syndrome representing deranged hemodynamics (such as tachycardia) secondary to severe infection. In high-income countries (HICs), early resuscitation of septic patients with protocol-driven therapy, including quantitative fluid administration guided by invasive monitoring, has resulted in improved outcomes for septic patients. Prevalence and mortality of sepsis are thought to be higher in sub-Saharan Africa (SSA) than in high-income countries; however, most hospitals in SSA lack the technology and resources necessary to implement the resuscitation protocols used in HICs and therefore, mortality from sepsis remains high. The World Health Organization (WHO) has recently disseminated an algorithm for resuscitation of septic patients in low resource settings. This algorithm is based on expert consensus only, and its efficacy has never been tested.

This study will be conducted in the Casualty Department of Moi Teaching and Referral Hospital (MTRH) in Eldoret, Kenya.

The purpose of this study is to describe the epidemiology of patients presenting with severe sepsis, to examine the microbiology causing severe sepsis, to describe current management and outcomes for severe sepsis, and to test the effect of implementation of the WHO resuscitation algorithm at MTRH.

The study design is a prospective before and after clinical trial. In an initial observational phase, adult patients presenting to the MTRH Casualty Department with sepsis and severe sepsis (the latter of which will be defined by elevated lactate) will be enrolled into a prospective observational cohort. Demographic data, medical characteristics, and microbiological studies will be obtained, then the management and outcomes of these patients will be observed. In a second phase, patients with sepsis will continue to be enrolled into a prospective observational cohort, while patients with severe sepsis will be enrolled into an intervention group. Patients in the intervention group will be managed according to the WHO resuscitation algorithm. Specifically, the WHO algorithm involves fluid boluses guided by vital signs and physical exam findings, rapid and early administration of empiric antibiotics, and frequent patient monitoring. The outcomes of interest are achievement of lactate clearance, which is a correlate of tissue perfusion, as well as 24-hour, in-hospital, and 30-day mortality.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Moi Teaching and Referral Hospital

Eldoret, Kenya

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Presenting to MTRH Casualty Department for acute medical care
  • Suspected infection, in the judgment of the managing clinician
  • At least 2 of the following: axillary temperature >37.5°C or <35.5°C or core temperature >38.0°C or <36.0°C; heart rate >90 beats per minute; respiratory rate >20 breaths per minute; or systolic blood pressure <100 mmHg

Exclusion criteria

  • Lack of basic language skills in either English or Kiswahili
  • Pregnancy
  • Congestive heart failure or valvular heart disease (as a known prior diagnosis or in the judgment of the managing clinician)
  • Need for immediate surgery (within 6 hours) in the judgment of the managing clinician
  • Inability to consent to study participation and lack of accompaniment by a family member or other surrogate who can provide consent

Treatment and study plan

WHO algorithm of fluid boluses guided by physical examination

Other

Frequent patient monitoring

Other

Vital signs and physical exam every 30-60 minutes

Early administration of empiric antibiotics

Other

Clinician will be prompted to administer antibiotics within 60 minutes

Oxygen delivery

Other

Correction of hypoglycemia

Other

If blood glucose is less than 3.0 mmol/L, IV dextrose will be administered

Correction of severe anemia

Other

If hemoglobin is less than 7 mg/dL, clinician will be prompted to offer blood transfusion

Primary outcomes

  1. Lactate clearance (difference in lactate [mmol/L] at study enrollment and 6 hours after study enrollment) as a measure of efficacy

    Time frame: enrollment, 6 hours

    Lactate level will be measured at study enrollment (time 0) and 6 hours after study enrollment (time 6). Lactate clearance will be reported as the difference between time 0 and time 6 lactate, as a fraction of time 0 lactate.

Secondary outcomes

  1. Mortality

    Time frame: 24 hours, in-hospital, and 30 days

  2. Number of subjects with adverse effects as a measure of safety

    Time frame: 6 hours, 24 hours, in-hospital, and 30 days

Other outcomes

  1. Time of first antibiotic delivery

    Time frame: 1 hour

  2. IV fluid volume (ml)

    Time frame: 6 hours, 24 hours, in-hospital

Sponsors and collaborators

Lead sponsor

Duke University

Other

Collaborators

  • Fogarty International Center of the National Institute of Health
  • Moi University

Registry information

Important dates

Study start
2015
Primary completion
2016
Study completion
2016
First posted
Jan 27, 2015
Registry last updated
Jan 5, 2018

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.